Tibet Rhodiola Pharmaceutical Holding Co., Ltd. logo

Tibet Rhodiola Pharmaceutical Holding Co., Ltd. (600211)

Market Open
7 Aug, 06:57
SSE SSE
¥
39. 56
+1.65
+4.3524%
¥
11.3B Market Cap
- P/E Ratio
3.87% Div Yield
6.09M Volume
- Eps
¥ 37.91
Previous Close
Add Transaction
Day Range
37.58 39.69
Year Range
34.8 57.98
Want to track 600211 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Tibet Rhodiola Pharmaceutical Holding Co., Ltd. (600211) Statistics

Valuation metrics

Market Cap 11.3B
Enterprise value 10.98B
Trailing P/E (ttm) 13.19
Forward P/E -
PEG ratio -3.17
Price/Sales (ttm) 4.26
Price/Book (mrq) 3.27
Enterprise Value/Revenue 3.67
Enterprise Value/EBITDA 9.65

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 3.79M
Average volume (90 days) 4M

Price summary

52-Week low 34.8
52-Week high 57.98
Beta -
50-Day moving average 38.32
200-Day moving average 40.39

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 1.76
Trailing annual dividend yield 0.0444%
5-Year annual dividend yield -
Payout ratio 1.18
Dividend Date 22 May 2026
Ex-Dividend Date 22 May 2026
Last split factor 1:1
Last split Date 30 Apr 2024

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin 0.32%
Operating margin 0.31%

Operational effectiveness

Return on assets 0.15%
Return on equity 0.25%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) 9.29
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 3
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 11.86
Total debt (mrq) -
Total Debt/Equity (mrq) 0.27
Current ratio (mrq) 2.88%
Book value per share (mrq) 13.12

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -